TSM Hits 52-Week High: Should You Hold the Stock or Book Profits?

TSMC reported robust Q3 2025 results with revenue up 41% YoY to $33.1 billion and EPS up 39% to $2.92, driven by strong demand for its 3nm and 5nm nodes which now represent ~60% of wafer sales and supported a 170 bps gross margin improvement to 59.5%. Management raised full-year 2025 revenue growth guidance to the mid-30% range, expects AI-related chip sales to be roughly 30% of revenue in 2025, and plans aggressive capex of $40–$42 billion in 2025 (vs. $29.8 billion in 2024); however, near-term headwinds include weak PC/smartphone markets, higher-cost US/Japan/Germany fabs that may shave 2–3ppt off margins, premium valuation (forward P/E ~26.74x vs sector 23.19x) and geopolitical/export risks tied to China, supporting a cautious 'hold' stance.

Analysis

Market structure: TSMC is a clear winner—3nm/5nm node scarcity gives it pricing power and material share gains versus smaller foundries; expect AI-related wafers to approach ~30% of revenue in 2025 and 60% of wafer mix at advanced nodes, tightening supply for advanced GPUs and driving ASPs up mid-single-digit percent annually. Downside hits are to legacy-node/PC/smartphone chipmakers and regional foundries that lack EUV capacity. Cross-asset: strength in TSMC supports risk-on flows (TWD appreciation, tighter HY spreads) and lifts semiconductor-equipment stocks (ASML, LRCX) while incremental capex raises corporate demand for USD funding, modestly pressuring front-end treasury yields if leverage rises.

Risk assessment: Tail risks include US export curbs or a China decoupling event that could knock 10–20% off revenue and/or sanction access to ASML EUV tools for Chinese fabs; new fabs in AZ/DE/JP could compress gross margins by ~200–300 bps for 3–5 years if utilization lags. Immediate (days) risks: earnings/guide misses; short-term (weeks–months): utilization/margin swings; long-term (years): structural AI demand trajectory and geopolitically driven capex. Hidden dependencies: ASML tool lead times, specialty-gas supply, and grid/energy availability at new fabs.

Trade implications: Tactical overweight TSMC vs peers—establish a modest 2–3% long TSM (add on dips < $310), hedge with 3–6 month puts if entering before earnings; consider a relative-value pair long TSM / short MRVL (size 2:1) to isolate foundry vs end-market execution risk. Use a 12-month call spread (e.g., buy Jan 2027 300C, sell Jan 2027 420C) sized to 0.5–1% notional to capture asymmetric upside while capping premium. Rotate 2–4% from PC/phone-exposed chip names into equipment suppliers (ASML, LRCX) and substrate suppliers for 12–24 months.

Contrarian angles: Consensus underestimates capex-driven margin pressure and political tail risk—valuation assumes continued margin expansion; if TSMC’s new-fab costs push gross margin down 200–300 bps or AI revenue growth falls below 30% y/y in next two quarters, re-rate could be 15–25% downside. Conversely, market may underprice long-term oligopoly rent capture if EUV capacity remains constrained through 2027—this asymmetry favors limited, hedged long structures over naked long exposure.

Key Decisions for Investors

• Establish a 2–3% long position in TSM (buy $TSM) now; add incremental size on pullback below $310. Set a 10% stop-loss and a 12-month target total return of +25–30%; trim half if 2026 AI revenue guide falls below 30% y/y.
• Implement a pair trade: long $TSM (2% notional) and short $MRVL (1% notional) to express foundry advantage vs end-market execution risk; rebalance if spread narrows by >15% or MRVL reports a design-win that materially increases server content share.
• Buy a capped upside options structure: Jan 2027 TSM 300/420 call spread sized to 0.5–1% of portfolio to capture upside while limiting premium; simultaneously sell 3–6 month 10–12% OTM calls to fund carry if comfortable with near-term income.
• Rotate 2–4% of semiconductor exposure from PC/phone-dominated names into equipment/supplier longs (e.g., $ASML, $LRCX) for 12–24 months to play structural capex; allocate only if ASML orderbook remains >12 months and LRCX backlog growth >20% y/y.
• Trigger-based risk control: within next 30–90 days, sharply reduce TSM exposure by 50% if (a) US/Allied export restrictions materially target advanced-node shipments to China, or (b) company guidance implies >200 bps gross-margin contraction or AI revenue growth <20% y/y.